BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18394270)

  • 1. Potential use of antiviral agents in polio eradication.
    De Palma AM; Pürstinger G; Wimmer E; Patick AK; Andries K; Rombaut B; De Clercq E; Neyts J
    Emerg Infect Dis; 2008 Apr; 14(4):545-51. PubMed ID: 18394270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Analysis of Antiviral Compounds Against Poliovirus.
    Leyssen P; Franco D; Tijsma A; Lacroix C; De Palma A; Neyts J
    Methods Mol Biol; 2016; 1387():325-38. PubMed ID: 26983743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case for developing antiviral drugs against polio.
    Collett MS; Neyts J; Modlin JF
    Antiviral Res; 2008 Sep; 79(3):179-87. PubMed ID: 18513807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyond.
    Thys B; De Palma AM; Neyts J; Andries K; Vrijsen R; Rombaut B
    Antiviral Res; 2008 Jun; 78(3):278-81. PubMed ID: 18294707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New small-molecule inhibitors effectively blocking picornavirus replication.
    Ford Siltz LA; Viktorova EG; Zhang B; Kouiavskaia D; Dragunsky E; Chumakov K; Isaacs L; Belov GA
    J Virol; 2014 Oct; 88(19):11091-107. PubMed ID: 25008939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poliovirus infection without accumulation of eclipse particles.
    Ofori-Anyinam O; Vrijsen R; Kronenberger P; Boeyé A
    Antiviral Res; 1995 Jan; 26(1):27-35. PubMed ID: 7741519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of the global eradication of poliomyelitis.
    Tangermann RH; Aylward B; Birmingham M; Horner R; Olivé JM; Nkowane BM; Hull HF; Burton A
    World Health Stat Q; 1997; 50(3-4):188-94. PubMed ID: 9477548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs.
    Duintjer Tebbens RJ; Pallansch MA; Thompson KM
    BMC Infect Dis; 2015 Sep; 15():379. PubMed ID: 26382043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Polio Eradication Initiative Strategic Plan, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Feb; 53(5):107-8. PubMed ID: 14961005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress towards the global eradication of poliomyelitis.
    Hull HF; Ward NA
    World Health Stat Q; 1992; 45(2-3):280-4. PubMed ID: 1462662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication.
    McKinlay MA; Collett MS; Hincks JR; Oberste MS; Pallansch MA; Okayasu H; Sutter RW; Modlin JF; Dowdle WR
    J Infect Dis; 2014 Nov; 210 Suppl 1():S447-53. PubMed ID: 25316866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative.
    Fine PE; Carneiro IA
    Am J Epidemiol; 1999 Nov; 150(10):1001-21. PubMed ID: 10568615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative.
    Dunn G; Klapsa D; Wilton T; Stone L; Minor PD; Martin J
    PLoS Pathog; 2015 Aug; 11(8):e1005114. PubMed ID: 26313548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress toward global eradication of poliomyelitis, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(12):253-6. PubMed ID: 11939704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The polio endgame.
    Minor P
    Hum Vaccin Immunother; 2014; 10(7):2106-8. PubMed ID: 25608050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1.
    Tijsma A; Thibaut HJ; Spieser SA; De Palma A; Koukni M; Rhoden E; Oberste S; Pürstinger G; Volny-Luraghi A; Martin J; Marchand A; Chaltin P; Neyts J; Leyssen P
    Antiviral Res; 2014 Oct; 110():1-9. PubMed ID: 25043639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Poliomyelitis eradication is a visible unsolved problem in the coming years].
    Seĭbil' VB; Malyshkina LP
    Vopr Virusol; 2011; 56(1):41-4. PubMed ID: 21427955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress toward poliomyelitis eradication--Pakistan, 1994-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Feb; 48(6):121-6. PubMed ID: 10073921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress toward global poliomyelitis eradication--1997-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 May; 48(20):416-21. PubMed ID: 10365631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.